U. D. Pete et al. / Bioorg. Med. Chem. Lett. 22 (2012) 5550–5554
5553
Table 3
Antifungal susceptibility testing of BCTU and BCU derivatives against human fungal pathogens
Compound
Growth Inhibitory concentration in
lg/ml
C. albicans NCIM
3557
C.
C. albicans NCIM
3471
C. glabrata NCIM
3237
C.
neoformans 3541
C. neoformans NCIM C. neoformans NCIM C. neoformans NCIM
albicans
3542
3378
4a
4b
4c
128
64
64
32
64
16
>512
>512
32
32
64
32
64
128
64
16
32
8
32
64
32
128
>512
32
ad
4e
4f
5a
5b
5c
5d
5e
128
64
256
512
128
64
>512
>512
>512
>512
128
128
64
64
>512
256
32
16
16
16
>512
128
>512
>512
>512
>512
>512
>512
32
32
32
>512
256
128
64
64
>512
>512
32
16
16
16
>512
128
32
16
64
32
32
>512
256
32
<4
<4
128
64
64
256
128
32
16
16
16
>512
128
512
128
128
>512
128
32
16
16
16
>512
128
512
>512
256
64
>512
>512
>512
>512
128
5f
<4
>512
128
Lufenuron
Carvacrol
antifungal activity against different strains of human pathogens C.
albicans, Candida glabrata and Cryptococcus neoformans
(Table 3). C. albicans and C. neoformans were isolates from clinical
samples whereas other strains and C. glabrata were procured from
National Centre for Industrially Important Microorganisms (NCIM),
Pune, India. All the BCTU derivatives showed potent antifungal
activity against these human pathogens. From BCU series, 5d, 5e
and 5f were most effective, whereas compounds 5a and 5b showed
weak or no antifungal activity against the tested strains. For most
of the compounds the activity was better than carvacrol against
human pathogens.
As stated earlier, carvacrol affects the cell membranes and re-
sults in depletion of sterols. Therefore, major concern of employ-
ing these newly synthesized compounds as crop protection or
antifungal agents is their potential toxicity to mammalian cells.
Hence, cellular toxicity of the compounds was checked by haem-
olysis assay as described previously.33 The concentrations tested
Supplementary data
Supplementary data associated with this article can be found, in
References and notes
1. Meunier, B. Acc. Chem. Res. 2007, 41, 69.
2. Graf, F. Parasitol. Today 1993, 9, 471.
3. Fournet, F.; Sannier, C.; Money, N. J. Am. Mos. Ctrl. Assoc. 1993, 4, 426.
4. Sannino, A.; Bandini, M. Rapid Commun. Mass Spectrom. 2005, 19, 2729.
5. Matsumura, F. Pestic. Biochem. Physiol. 2010, 97, 133.
6. Johnson, S. M.; Zimmermann, C. R.; Kerekes, K. M.; Davidson, A.; Pappagianis, D.
Med. Mycol. 1999, 37, 441.
7. Scotty, N. C.; Evans, T. J.; Giuliano, E.; Johnson, P. J.; Rottinghaus, G. E.;
Fothergill, A. W.; Cutler, T. J. J. Vet. Intern. Med. 2005, 19, 878.
8. Enomoto, S.; Asano, R.; Iwahori, Y.; Narui, T.; Okada, Y. Biol. Pharm. Bull. 2001,
24, 307.
9. Skocibusic, M.; Besic, N. Phytother. Res. 2004, 18, 967.
10. Vicenzi, M.; Stammati, A.; Vicenzi, A.; Silano, M. Fitoterapia 2004, 75, 801.
11. Mueller-Riebau, F.; Berger, B.; Yegen, O. Agric J. Food Chem. 1995, 43, 2262.
12. Kordali, S.; Cakir, A.; Ozer, H.; Cakmakci, R.; Kesdek, M.; Mete, E. Bioresour.
Technol. 2008, 99, 8788.
13. Chami, N.; Chami, F.; Bennis, S.; Trouillas, J.; Remmal, A. Braz. J. Infect. Dis. 2004,
8, 217.
14. Pinto, E.; Pina-Vaz, C.; Salgueiro, L.; Goncalves, M. J.; Costa-de-Oliveira, S.;
Cavaleiro, C.; Palmeira, A.; Rodrigues, A.; Martinez-de-Oliveira, J. J. Med.
Microbiol. 2006, 55, 1367.
15. Rao, A.; Zhang, Y.; Muend, S.; Rao, R. Antimicrob. Agents Chemother. 2010, 54,
5062.
16. Lee, S. G.; Kim, S. I.; Ahn, Y. J.; Kim, J. B.; Lee, B. Y. Pestic. Sci. 1997, 49, 119.
17. Tang, X.; Chen, S.; Wang, L. Nat. Prod. Res. 2011, 25, 320.
18. Shah, H.; Vashi, S.; Mehta, S. Indian J. Che. 1995, 34B, 802.
19. Kremers, E.; Wakeman, N.; Hixon, R. Org. Syn. 1941, 1, 511.
20. General synthetic procedure for the synthesis of 4a–f: To a hot, vigorously
stirred solution of ammonium thiocyanate (0.84 g, 0.011 mol) in dry acetone
(20 mL), substituted benzoyl chloride (0.011 mol) in dry acetone (10 mL) was
added drop wise. The reaction mixture was stirred on a hot plate for 1.5 h and
it was added to an equimolar quantity of the 4-aminocarvacrol (1.82 g,
0.011 mol) in dry acetone (10 mL). The mixture was refluxed for 5–6 h at 55 °C.
The solvent was then removed under reduced pressure and the reaction
mixture was diluted with ice cold water (50 mL) to afford the product. The
separated solid was purified by recrystallization from hexane–ethyl acetate
mixture. Yields obtained are about 70 to 80%.
21. General synthetic procedure for the synthesis of 5a–f: Respective thioureas
(0.0033 mol) were dissolved in DMF and 85 % (15 mL) formic acid and 30%
hydrogen peroxide (50 mL) were slowly added to the solution. The reaction
mixture was stirred overnight and poured onto crushed ice. The precipitate
was collected, dried and recrystallized from hexane–ethyl acetate mixture to
afford the product.
were in the range of 4–1000
50% haemolysis (HC50) for all the BCTU, BCU compounds and
lufenuron was >1000 g/ml. Maximum haemolysis observed was
17% for compound 4e at 1000 g/ml concentration. At MIC con-
centrations for all the derivatives, the haemolysis was negligible
(<2%). The HC50 values for carvacrol and a similarly acting anti-
lg/ml. The concentration causing
l
l
fungal drug Amphoterecin B were 250 and 8 lg/ml, respectively.
The antifungal activity and haemolysis results indicated that the
synthesized compounds are better and safer than BPU’s and
carvacrol.
In conclusion, two series of BCTU and BCU derivatives were syn-
thesized by structurally modifying carvacrol and introducing ben-
zoylphenyl urea linkage. Derivatives 4b, 4d, 4e, 4f and 5d, 5f
showed comparable Insect growth regulator activity with the stan-
dard BPU lufenuron against D. koenigii. Most of the compounds
demonstrated potent antifungal activity against human pathogens
and potent to moderate activity against different phytopathogens
and food spoilage yeasts. All the compounds were non-haemolytic.
The synthesized compounds have a potential application in agri-
culture as safer and broad spectrum crop protection agents. After
comprehensive evaluation, they may also be used for the control
of fungal pathogens in veterinary and human healthcare.
Acknowledgments
22. Data for 1-benzoyl-3-(4-hydroxy-2-methyl-5-isopropylphenyl) thiourea (4a):
White solid, mp 208 °C, 1H NMR (300 MHz, CDCl3, 25 °C): d = 1.22 (d,
J = 6.87 Hz, 6 H, CH(CH3)2), 2.24 (s, 3 H, CH3), 3.05 (m, 1 H, CH(CH3)3), 5.06
(bs, 1 H, OH), 6.77 (s, 1 H, H-Ar), 7.27 (s, 1 H, H-Ar), 7.55 (t, 1 H, H-Ar), 7.64 (t, 2
H, H-Ar), 7.91 (d, J = 7.32 Hz, 2 H, H-Ar), 9.26 (bs, 1 H, NH), 11.98 (brs, 1 H, NH)
ppm. LC–MS calcd for C18H21N2O2S [M+H]+ 329.44 , found 329.00. C18H20N2O2S
(328.44): C, 65.83; H, 6.14; N, 8.53; S, 9.76; found C, 66.22; H, 6.17; N, 8.49.
Mr. Umesh Pete and Ratnamala Bendre are thankful to
University Grants Commission, New Delhi, India, for the financial
assistance. Santosh Tupe and Preeti Chaudhary thanks Council of
Scientific and Industrial Research, India for the research fellowship.